<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36718227</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-6502</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>eNeurologicalSci</Title><ISOAbbreviation>eNeurologicalSci</ISOAbbreviation></Journal><ArticleTitle>Demonstrating new-onset or worsened sudomotor function post-COVID-19 on comparative analysis of autonomic function pre-and post-SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>100445</StartPage><MedlinePgn>100445</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100445</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ensci.2023.100445</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Autonomic dysfunction including sudomotor abnormalities have been reported in association with SARS-CoV-2 infection.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">There are no previous studies that have compared autonomic function objectively in patients pre- and post- SARS-CoV-2 infection.We aimed to identify if SARS-CoV-2 virus is triggering and/or worsening dysautonomia by comparing autonomic function tests in a group of patients pre-and post-SARS-CoV-2 infection.</AbstractText><AbstractText Label="DESIGN/METHODS" NlmCategory="UNASSIGNED">Six participants were enrolled and divided into two groups. The first group of 4 participants reported worsened autonomic symptoms post-SARS-CoV-2 infection. These individuals had their first autonomic test prior to COVID-19 pandemic outbreak (July 2019-December 2019). Autonomic function testing was repeated in these participants, 6&#xa0;months to 1-year post-SARS-CoV-2 infection (June 2021).The second group of 2 participants reported new-onset autonomic symptoms post-COVID-19 infection and were also tested within 6&#xa0;months post-SARS-CoV-2 infection.All participants had mild COVID-19 infection per WHO criteria. They had no evidence of large fiber neuropathy as demonstrated by normal neurophysiological studies (EMG/NCS). They were all screened for known causes of autonomic dysfunction and without risk factors of hypertension/hyperlipidemia, thyroid dysfunction, diabetes/prediabetes, vitamin deficiencies, history of HIV, hepatitis, or syphilis, prior radiation or chemical exposure or evidence of monoclonal gammopathy, or autoimmune condition.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Participants were female (age: 21-37y) and all endorsed orthostatic intolerance (6/6). Gastrointestinal symptoms (&#x215a;), new-onset paresthesias, (3/6), and sexual dysfunction (2/6) were reported. Parasympathetic autonomic function remained stable 6-months to 1-year post-COVID-19 infection and no parasympathetic dysfunction was demonstrated in participants with new-onset dysautonomia symptoms. Postural orthostatic tachycardia was noted in half of the patients, being observed in one patient pre- SARS-CoV-2 infection and persisting post-SARS-CoV-2 infection; while new-onset postural tachycardia was observed in 1/3rd of patients. Sympathetic cholinergic (sudomotor) dysfunction was demonstrated in ALL participants. Worsened, or new-onset, sudomotor dysfunction was demonstrated in those with mild or normal sudomotor function on pre-COVID-19 autonomic testing.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Sympathetic adrenergic and cholinergic dysautonomia probably account for some of the symptoms of Long COVID-19. Sudomotor dysfunction was demonstrated as consistently worsened or new-sequelae to COVID-19 infection. COVID-19 may be responsible for triggering new-onset or worsened small-fiber neuropathy in this sample, supporting previously reported studies with similar findings. However, the findings in our study are preliminary, and studies with larger sample size are needed to confirm these observations.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Varma-Doyle</LastName><ForeName>Aditi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Louisiana State University Health Sciences Center, New Orleans School of Medicine, Department of Neurology, New Orleans, LA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Massachusetts General Hospital, Harvard Medical School, Department of Neurology, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villemarette-Pittman</LastName><ForeName>Nicole R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Louisiana State University Health Sciences Center, New Orleans School of Medicine, Department of Neurology, New Orleans, LA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ochsner Health, New Orleans, LA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Queensland Medical School, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lelorier</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Louisiana State University Health Sciences Center, New Orleans School of Medicine, Department of Medicine, Section of Cardiology, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>England</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Louisiana State University Health Sciences Center, New Orleans School of Medicine, Department of Neurology, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>eNeurologicalSci</MedlineTA><NlmUniqueID>101667077</NlmUniqueID><ISSNLinking>2405-6502</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Neurocardiogenic syncope</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 dysautonomia</Keyword><Keyword MajorTopicYN="N">Postural orthostatic tachycardia</Keyword><Keyword MajorTopicYN="N">Small-fiber neuropathy</Keyword></KeywordList><CoiStatement>There are no conflicts of interest, real or perceived in the preparation or submission of this manuscript for publication.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>31</Day><Hour>1</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36718227</ArticleId><ArticleId IdType="pmc">PMC9877150</ArticleId><ArticleId IdType="doi">10.1016/j.ensci.2023.100445</ArticleId><ArticleId IdType="pii">S2405-6502(23)00003-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Finsterer J. Small fiber neuropathy underlying dysautonomia in COVID-19 and in post-SARS-CoV-2 vaccination and long-COVID syndromes. Muscle Nerve. 2022 Jun;65(6):E31&#x2013;E32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9088382</ArticleId><ArticleId IdType="pubmed">35385125</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurologicalSci. 2020 Dec;21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7502253</ArticleId><ArticleId IdType="pubmed">32984564</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A.L., Mills A.J., Kelley M., et al. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol. Neuroimmunol. Neuroinflamm. 2022 Mar 1;9(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams R.M.C., Simpson D.M., Navis A., et al. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve. 2022 Apr;65(4):440&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661991</ArticleId><ArticleId IdType="pubmed">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K., Vanichkachorn G., Cheshire W.P., et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin. Auton. Res. 2021 Jun;31(3):385&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol. Res. 2021 Apr;69(2):205&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Stella Buoite, Alex, et al. Autonomic dysfunction in post-COVID patients with and without neurological symptoms: a prospective multidomain observational study. J. Neurol. 2022;269(2):587&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8359764</ArticleId><ArticleId IdType="pubmed">34386903</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurologicalSci. 2020 Dec;21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7502253</ArticleId><ArticleId IdType="pubmed">32984564</ArticleId></ArticleIdList></Reference><Reference><Citation>Canetta C., Accordino S., Buscarini E., et al. Syncope at SARS-CoV-2 onset. Auton. Neurosci. 2020 Dec;229</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7505046</ArticleId><ArticleId IdType="pubmed">32977101</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldokla A.M., Ali S.T. Autonomic function testing in long-COVID syndrome patients with orthostatic intolerance. Auton. Neurosci. 2022 Jun 2;241</Citation><ArticleIdList><ArticleId IdType="pubmed">35679657</ArticleId></ArticleIdList></Reference><Reference><Citation>Doblan A., Kaplama M.E., Ak S., et al. Cranial nerve involvement in COVID-19. Am. J. Otolaryngol. 2021 Sep-Oct;42(5):102999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997027</ArticleId><ArticleId IdType="pubmed">33838359</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiers S., Ray Pradipta R., Wangzhou A., et al. ACE2 and SCARF expression in human dorsal root ganglion nociceptors: implications for SARS-CoV-2 virus neurological effects. Pain. 2020;161:2494&#x2013;2501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7572821</ArticleId><ArticleId IdType="pubmed">32826754</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A.L. Clinical significance of angiotensin-converting enzyme 2 receptors for severe acute respiratory syndrome coronavirus 2 (COVID-19) on peripheral small-fiber sensory neurons is unknown today. Pain. 2020 Nov;161(11):2431&#x2013;2433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10034827</ArticleId><ArticleId IdType="pubmed">32826753</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinduja A., Moutairou A., Calvet J.H. Sudomotor dysfunction in patients recovered from COVID-19. Neurophysiol. Clin. 2021;51(2):193&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7835104</ArticleId><ArticleId IdType="pubmed">33551341</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>